MFDS — authorised 10 October 2019
- Marketing authorisation holder: VERTEX PHARMS INC
- Status: likely_approved
🇰🇷 Trikafta (Copackaged) in South Korea
MFDS authorised Trikafta (Copackaged) on 10 October 2019
Marketing authorisation
Trikafta (Copackaged) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in South Korea
Frequently asked questions
Is Trikafta (Copackaged) approved in South Korea?
Yes. MFDS authorised it on 10 October 2019.
Who is the marketing authorisation holder for Trikafta (Copackaged) in South Korea?
VERTEX PHARMS INC holds the South Korean marketing authorisation.